| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa255193591246c274574c67e13e8084 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H21-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 |
| filingDate |
1996-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51004ddc751988975e3c9d01195c2ac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b971a926f1e6d5223a3fc2f08bddcb5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0498a005beb1a7634f41b69fceda20f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f487f6eea8d4d8c41308f682488e815f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95db1a810fb3ff219b710ef3c098bc96 |
| publicationDate |
1998-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0821001-A1 |
| titleOfInvention |
Amidite derivatives and oligonucleotide derivatives |
| abstract |
Compounds represented by general formula (I) (wherein X represents a groupnrepresented by general formula (II) or (III); Y represents a leaving group; andnZ represents an oligonucleotide etc.). These compounds can specificallyntransfer oligonucleotides into cells that specifically recognize specifiednsugar structures and hence can be used as antiviral and antitumor agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020514383-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023002452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019232255-A1 |
| priorityDate |
1995-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |